Literature DB >> 36254052

Construction of a transcription factor-miRNA-mRNA interactive network elucidates underlying pathogenesis for osteosarcoma and validation by qRT-PCR.

Fuxing Tang1, Xiaohong Jiang, Shijie Liao, Yun Liu, Maolin He.   

Abstract

PURPOSE: Osteosarcoma is characterized by features of rapid growth and early metastasis with a poor prognosis. The aim of our research is to investigate the potential transcription factor (TF)-miRNA-mRNA regulatory mechanism in osteosarcoma utilizing bioinformatics methods and validate by qRT-PCR.
METHODS: The microRNA (miRNA) expression profiling datasets (GSE28423 and GSE65071) and mRNA expression profiling dataset GSE33382 were collected from the Gene Expression Omnibus (GEO) database. Differentially expressed miRNAs (DEMs) and differentially expressed genes (DEGs) were screened using the limma package. Then, the TransmiR v2.0, miRDB, and Targetscan 7.2 database were applied for the acquisition of TF-miRNA and miRNA-mRNA interaction relationships, respectively. Finally, we built a TF-miRNA-mRNA interactive network. Furthermore, survival analysis was performed to identify sub-network with prognostic value and validate through qRT-PCR.
RESULTS: Eight overlapping DEMs and 682 DEGs were identified. Based on bioinformatics methods, 30 TF-miRNA interaction pairs and 25 miRNA-mRNA interaction pairs were screened. Finally, we constructed a TF-miRNA-mRNA regulatory network. Furthermore, laminin subunit gamma 1 (LAMC1) and thrombospondin-1 (THBS1), which involved in the network, were determined to have prognostic value and the corresponding subnetwork was identified. qRT-PCR results showed that LAMC1 mRNA expression was higher in osteosarcoma cells.
CONCLUSION: Based on the survival analysis, a TF-miRNA-mRNA sub-network, that is TFs (SPI1, HEY1, and CEBPB)-hsa-miR-338-3p-target genes (LAMC1 and THBS1) was established. In conclusion, the construction of a potential TF-related regulatory network will help elucidate the underlying pathological mechanisms of osteosarcoma, and may provide novel insights for the diagnosis and treatment of osteosarcoma.
Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 36254052      PMCID: PMC9575767          DOI: 10.1097/MD.0000000000031049

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.817


  34 in total

1.  Specificity of microRNA target selection in translational repression.

Authors:  John G Doench; Phillip A Sharp
Journal:  Genes Dev       Date:  2004-03-10       Impact factor: 11.361

2.  Introduction to "a handbook of transcription factors".

Authors:  T R Hughes
Journal:  Subcell Biochem       Date:  2011

3.  Thrombospondin-1 is part of a Slug-independent motility and metastatic program in cutaneous melanoma, in association with VEGFR-1 and FGF-2.

Authors:  Patrizia Borsotti; Carmen Ghilardi; Paola Ostano; Antonietta Silini; Romina Dossi; Denise Pinessi; Chiara Foglieni; Maria Scatolini; Pedro M Lacal; Raffaele Ferrari; Davide Moscatelli; Fabio Sangalli; Stefania D'Atri; Raffaella Giavazzi; Maria Rosa Bani; Giovanna Chiorino; Giulia Taraboletti
Journal:  Pigment Cell Melanoma Res       Date:  2014-10-13       Impact factor: 4.693

4.  Targeting transcription factors in cancer: Challenges and evolving strategies.

Authors:  Michele S Redell; David J Tweardy
Journal:  Drug Discov Today Technol       Date:  2006

Review 5.  Osteosarcoma: A comprehensive review of management and treatment strategies.

Authors:  Farzaneh Jafari; Saeed Javdansirat; Sarvin Sanaie; Amirreza Naseri; Ali Shamekh; Davood Rostamzadeh; Sanam Dolati
Journal:  Ann Diagn Pathol       Date:  2020-10-25       Impact factor: 2.090

Review 6.  Laminin isoforms in tumor invasion, angiogenesis and metastasis.

Authors:  Manuel Patarroyo; Karl Tryggvason; Ismo Virtanen
Journal:  Semin Cancer Biol       Date:  2002-06       Impact factor: 15.707

7.  miR-338-3p suppresses neuroblastoma proliferation, invasion and migration through targeting PREX2a.

Authors:  Xin Chen; Min Pan; Lulu Han; Hongting Lu; Xiwei Hao; Qian Dong
Journal:  FEBS Lett       Date:  2013-10-15       Impact factor: 4.124

8.  Deciphering the complex role of thrombospondin-1 in glioblastoma development.

Authors:  Thomas Daubon; Céline Léon; Kim Clarke; Laetitia Andrique; Laura Salabert; Elodie Darbo; Raphael Pineau; Sylvaine Guérit; Marlène Maitre; Stéphane Dedieu; Albin Jeanne; Sabine Bailly; Jean-Jacques Feige; Hrvoje Miletic; Marco Rossi; Lorenzo Bello; Francesco Falciani; Rolf Bjerkvig; Andréas Bikfalvi
Journal:  Nat Commun       Date:  2019-03-08       Impact factor: 14.919

9.  LAMC1 is a prognostic factor and a potential therapeutic target in endometrial cancer.

Authors:  Haruko Kunitomi; Yusuke Kobayashi; Ren Chin Wu; Takashi Takeda; Eiichiro Tominaga; Kouji Banno; Daisuke Aoki
Journal:  J Gynecol Oncol       Date:  2019-08-21       Impact factor: 4.401

10.  Thrombospondin-1 promotes cell migration, invasion and lung metastasis of osteosarcoma through FAK dependent pathway.

Authors:  Chuanzhen Hu; Junxiang Wen; Liangzhi Gong; Xu Chen; Jun Wang; Fangqiong Hu; Qi Zhou; Jing Liang; Li Wei; Yuhui Shen; Weibin Zhang
Journal:  Oncotarget       Date:  2017-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.